Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 7.35 | 11.77 | 5.19 | 5.83 |
Depreciation/ Depletion | 5.00 | 5.33 | 5.49 | 4.48 |
Non- Cash Items | 3.03 | 1.62 | 1.57 | -0.66 |
Changesin Working Capital | -5.89 | -13.77 | -2.53 | -23.25 |
Cashfrom Operating Activities | 9.48 | 4.95 | 9.73 | -13.61 |
Capital Expenditures | -15.85 | -8.22 | -7.54 | -6.09 |
Other Investing Cash Flow Items Total | 0.79 | 0.73 | 1.00 | 0.75 |
Cashfrom Investing Activities | -15.05 | -7.49 | -6.54 | -5.35 |
Financing Cash Flow Items | -2.31 | -1.69 | -0.09 | -0.09 |
Issuance( Retirement)of Debt Net | 1.47 | 11.86 | -4.73 | 12.37 |
Cashfrom Financing Activities | -0.85 | 10.18 | -4.81 | 12.28 |
Net Changein Cash | -6.41 | 7.64 | -1.63 | -6.68 |
Cash Interest Paid | 2.31 | 1.69 | 0.09 | 0.09 |
Cash Taxes Paid | 0.17 | 0.13 | 0.17 | - |
Issuance( Retirement)of Stock Net | - | - | - | 0.00 |
Bafnapharm Dividend Bafnapharm Bonus Bafnapharm News Bafnapharm AGM Bafnapharm Rights Bafnapharm Splits Bafnapharm Board Meetings Bafnapharm Key Metrics Bafnapharm Shareholdings Bafnapharm Profit Loss Bafnapharm Balance Sheet Bafnapharm Q1 Results Bafnapharm Q2 Results Bafnapharm Q3 Results Bafnapharm Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks